Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone

Clinical trial NCT00004645 · UNKNOWN

Trial details

NCT number: NCT00004645
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Disseminated Encephalomyelitis Devic's Syndrome Marburg's Variant of Multiple Sclerosis Balo's Concentric Sclerosis Acute Transverse Myelitis

Start date: 1995-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.